Some countries, including Iceland, have taken a more flexible stance and not enforced such regulations for clozapine
prescriptions in view of the fact that there is no other alternative drug available with similar efficacy for treatment resistant schizophrenia, as well as the practical difficulties of regular monitoring in remote areas